Business ❯Corporate Governance ❯Investor Relations

Shareholder Rights

Litigation Class Action Lawsuits Legal Representation Loss Recovery Class Action Participation Legal Compliance Securities Fraud Class Action Representation Securities Claims Legal Rights of Investors Class Action Claims Securities Class Actions Lead Plaintiff CEO Responsibilities Securities Litigation Legal Recourse Fraudulent Practices Investor Compensation Legal Obligations

FDA Rejects Aldeyra's Reproxalap NDA for Dry Eye Disease Over Efficacy Issues

The decision marks the second rejection of the drug application, with Aldeyra planning a mid-2025 resubmission pending new trial results.

Supreme Court Reviews Nvidia's Challenge to Securities Fraud Lawsuit

Elizabeth Warren Challenges Tesla Board Over Musk's Corporate Conflicts